Opioids and immune modulation: more questions than answers

Risdahl, 1998, Opiates and infection, J Immunol, 83, 4

Hussey, 1950, Infections resulting from narcotic addiction; report of 102 cases, Am J Med, 9, 186, 10.1016/0002-9343(50)90021-0

Nincovi, 2011, Role of the mu-opioid receptors in opioid modulation of immune function, Amino Acids

Byrant, 1988, Morphine pellet induced immunomodulation in mice: temporal relationships, J Pharmacol Exp Ther, 245, 913

Byrant, 1988, Morphine-induced immunomodulation is not related to serum morphine concentration, Eur J Pharmacol, 149, 165, 10.1016/0014-2999(88)90057-X

Byrant, 1991, Role of adrenal cortical activation in the immunosuppressive effect of chronic morphine treatment, Endocrinology, 128, 3253, 10.1210/endo-128-6-3253

Roy, 2001, Morphine directs T cells toward T(H2) differentiation, Surgery, 130, 304, 10.1067/msy.2001.116033

Gaveriaux-Ruff, 1998, Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene, Proc Natl Acad Sci USA, 95, 6326, 10.1073/pnas.95.11.6326

Bussiere, 1993, Cytokine reversal of morphine-induced suppression of the antibody response, J Pharmacol Exp Ther, 264, 591

Bhargava, 1994, Effects of morphine tolerance and abstinence on cellular immune function, Brain Res, 642, 1, 10.1016/0006-8993(94)90899-0

Bussiere, 1992, Differential effect of morphine and naltrexone on the antibody response in various mouse strains, Immunopharmacol Immunotoxicol, 14, 657, 10.3109/08923979209005416

Pacifici, 2000, Pharmacokinetics and cytokine production in heroin and morphine-treated mice, Int J Immunopharmacol, 22, 603, 10.1016/S0192-0561(00)00023-0

Wang, 2003, Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways, J Biol Chem, 278, 37622, 10.1074/jbc.M301224200

Borner, 2008, T-cell receptor/CD28-mediated activation of human T lymphocytes induced expression of functional mu-opioid receptors, Mol Pharmacol, 74, 496, 10.1124/mol.108.046029

Roy, 2006, Modulation of immune function by morphine: implications for susceptibility to infection, J Neuro Immune Pharmacol, 1, 77, 10.1007/s11481-005-9009-8

Casellas, 1991, Inhibition by opioids of phagocytosis in peritoneal macrophages, Neuropeptides, 18, 35, 10.1016/0143-4179(91)90161-B

Perez-Castrillon, 1992, Opioids depress in vitro human monocyte chemotaxis, Immunopharmacol, 23, 57, 10.1016/0162-3109(92)90009-2

Szebo, 1993, Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids, J Pharmacol Exp, 267, 703

Sharp, 1985, Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages, Endocrinology, 117, 793, 10.1210/endo-117-2-793

Simpkins, 1986, The effect of enkephalins and prostaglandins on O-2 release by neutrophils, J Surg Res, 41, 645, 10.1016/0022-4804(86)90090-9

Welters, 2000, Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by nitric oxide and mu(3) opiate receptor-dependent mechanisms, J Neuroimmunol, 111, 139, 10.1016/S0165-5728(00)00401-X

Grimm, 1998, Opiate inhibition of chemokine induced chemotaxis, Ann NY Acad Sci, 840, 9, 10.1111/j.1749-6632.1998.tb09544.x

Simpkins, 1984, Human neutrophil migration is enhanced by beta-endorphin, Life Sci, 34, 2251, 10.1016/0024-3205(84)90213-3

Martin, 2010, Chronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site, Am J Pathol, 176, 786, 10.2353/ajpath.2010.090457

Frenklakh, 2006, Morphine-induced degradation of the host defence barrier role of intestinal mucosal injury, Dig Dis Sci, 51, 318, 10.1007/s10620-006-3132-0

Min, 2011, Morphine post-conditioning attenuates ICAM-1 expression on endothelial cells, J Korean Med Sci, 26, 290, 10.3346/jkms.2011.26.2.290

Chang, 2011, Influence of morphine on host immunity, Acta Anaesthesiol Taiwan, 46, 105, 10.1016/j.aat.2011.08.003

Vuong, 2010, The effects of opioids and opioid analogues on animal and human endocrine systems, Endocr Rev, 31, 98, 10.1210/er.2009-0009

Hoffmann, 1980, The ‘Intelligence’ of Antigen-specific Receptors from a Network Point of View, 401

Erb, 1984, What is immunoregulation?, Agents Actions, 15, 59, 10.1007/BF01966966

Pert, 1973, Opiate receptor: demonstration in nervous tissue, Science, 179, 1011, 10.1126/science.179.4077.1011

Lord, 1977, Endogenous opioid peptides: multiple agonists and receptors, Nature, 267, 495, 10.1038/267495a0

Olson, 1993, Endogenous opiates: 1992, Peptides, 14, 1339, 10.1016/0196-9781(93)90195-M

Zadina, 1997, A potent and selective endogenous agonist for the mu-opiate receptor, Nature, 386, 499, 10.1038/386499a0

Kieffer, 1992, The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization, Proc Natl Acad Sci USA, 89, 12048, 10.1073/pnas.89.24.12048

Evans, 1992, Cloning of a delta opioid receptor by functional expression, Science, 258, 1952, 10.1126/science.1335167

Granier, 2012, Structure of the δ-opioid receptor bound to naltrindole, Nature, 485, 400, 10.1038/nature11111

Thompson, 2012, Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic, Nature, 485, 395, 10.1038/nature11085

Wu, 2012, Structure of the human κ-opioid receptor in complex with JDTic, Nature, 485, 327, 10.1038/nature10939

Manglik, 2012, Crystal structure of the µ-opioid receptor bound to a morphine antagonist, Nature, 485, 321, 10.1038/nature10954

Dietis, 2011, Opioid receptor subtypes: fact or artefact?, Br J Anaesth, 107, 8, 10.1093/bja/aer115

Lambert, 2008, The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential, Nat Rev Drug Discov, 7, 694, 10.1038/nrd2572

Dietis, 2009, Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile, Br J Anaesth, 103, 38, 10.1093/bja/aep129

Sacerdote, 2006, Opioids and the immune system, Palliat Med, 20, s9, 10.1191/0269216306pm1124oa

The British Pain Society's opioids for persistent pain: Good practice, 2010 Available from http://www.britishpainsociety.org/book_opioid_main.pdf (accessed 30 January 2013).

Sacerdote, 2003, Experimental evidence for immunomodulatory effects of opioids, Adv Exp Med Biol, 521, 106

Sacerdote, 1997, Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study, Br J Pharmacol, 121, 834, 10.1038/sj.bjp.0701138

Jacobs, 1999, Effects of fentanyl on cellular immune function I man, Int J Immunopharmacol, 21, 445, 10.1016/S0192-0561(99)00025-9

Odunayo, 2010, Immunomodulatory effects of opioids, J Vet Emerg Crit Care, 20, 376, 10.1111/j.1476-4431.2010.00561.x

Roy, 1998, Mu-opioid receptor-knockout mice: role of mu-opioid receptors in morphine mediated immune receptors in morphine mediated immune function, Brain Res, 61, 190

Nelson, 2000, Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation, Brain Behav Immun, 14, 170, 10.1006/brbi.1999.0575

Hernandez, 1993, Immunosuppression by morphine is mediated by central pathways, J Pharmacol Exp Ther, 267, 1336

Shavit, 1986, Involvement of brain opiate receptors in the immune-suppressive effect of morphine, Proc Natl Acad Sci USA, 83, 7114, 10.1073/pnas.83.18.7114

Hall, 1998, Opioid mediated effects on the immune system: sympathetic nervous system involvement, J Neuroimmunol, 83, 29, 10.1016/S0165-5728(97)00218-X

Vallejo, 2004, Opioid therapy and immunosuppression: a review, Am J Ther, 11, 354, 10.1097/01.mjt.0000132250.95650.85

Bidlack, 2000, Detection and function of opioid receptors on cells from the immune system, Clin Diag Lab Immunol, 7, 719, 10.1128/CDLI.7.5.719-723.2000

Cedat, 2001, Real-time PT-PCR measurement of the modulation of Mu opioid receptor expression by nitric oxide in human mononuclear cells, J Immunol, 170, 1123

Calderioli, 1999, Neutrophil function and opioid receptor expression on leucocytes during chronic naltrexone treatment in humans, Pharmacol Res, 20, 153, 10.1006/phrs.1999.0488

Chuang, 1995, Mu Opioid receptor gene expression in immune cells, Biochem Biophys Res Commun, 216, 922, 10.1006/bbrc.1995.2709

Mehrishi, 1983, Opiate receptors on Lymphocytes and platelets in man, Clin Immunol Immunopathol, 27, 240, 10.1016/0090-1229(83)90074-0

Beck, 2002, Opioid receptors on white blood cells: effect of HIV infection and methadone treatment, Pain, 98, 187, 10.1016/S0304-3959(02)00044-1

Suzuki, 2000, Morphine upregulates mu opioid receptors of human and monkey lymphocytes, Biochem Biophys Res Commun, 279, 621, 10.1006/bbrc.2000.4006

Williams, 2007, Human peripheral blood mononuclear cells express nociception/orphanin FQ, but not mu, delta, or kappa opioid receptors, Anaesth Analg, 105, 998, 10.1213/01.ane.0000278865.11991.9d

JP Williams, Opioids and a Neuro-Vascular-Immune axis, University of Leicester doctoral thesis 2008 Available from http://hdl.handle.net/2381/4160 (accessed 4 February 2013).

M Al-Hashimi, J McDonald, JP Thompson, DG Lambert, Classical opioid receptor mRNA is NOT present in whole human blood, Anaesthetic Research Society Winter Scientific Meeting, Abstract presentation booklet. Br J Anaesth in press.

Castro, 2011, Physiology and pathophysiology of the HPA axis, Cushing's Syndr Contemp Endocrinol, 1

Franchimont, 2004, Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies, Ann NY Acad Sci, 1024, 124, 10.1196/annals.1321.009

Facchinetti, 1984, Impaired circadian rhythmicity of beta-lipotrophin, beta-endorphin and ACTH in heroin addicts, Acta Endocrinol (Copenh), 105, 149, 10.1530/acta.0.1050149

Serrano-Gomez, 2011, Nociceptin/orphanin FQ in inflammation and sepsis, Br J Anaesth, 106, 6, 10.1093/bja/aeq337

Stamer, 2011, Expression of the nociceptin precursor and nociceptin receptor is modulated in cancer and septic patients, Br J Anaesth, 106, 566, 10.1093/bja/aer007

Williams, 2008, Nociceptin and urotensin-II concentrations in critically ill patients with sepsis, Br J Anaesth, 100, 810, 10.1093/bja/aen093

Anton, 2010, Nociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro, J Neuroimmune Pharmacol, 5, 143, 10.1007/s11481-010-9190-2

Alt, 2012, Nociceptin/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis, Eur J Pharmacol, 683, 285, 10.1016/j.ejphar.2012.03.014

Williams, 2008, Human peripheral blood mononuclear cells produce pre-pro-nociceptin/orphanin FQ mRNA, Anesth Analg, 106, 865, 10.1213/ane.0b013e3181617646

McDonald, 2010, Use of preparative fluorescence activated cell sorting (FACS) to profile opioid receptor and peptide mRNA expression on human granulocytes, lymphocytes and monocytes, Br J Anaesth, 105, 707

Fiset, 2003, Human neutrophils as a source of nociceptin: a novel link between pain and inflammation, Biochemistry (Mosc), 42, 10498, 10.1021/bi0300635

Serhan, 2001, Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4, J Immunol, 166, 3650, 10.4049/jimmunol.166.6.3650

Trombella, 2005, Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation, Peptides, 26, 1497, 10.1016/j.peptides.2005.03.015

Donica, 2011, Orphanin FQ/nociceptin activates nuclear factor kappa B, J Neuroimmune Pharmacol, 6, 617, 10.1007/s11481-011-9279-2

Schultz, 1977, Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)- opioid receptor in the intact rat heart, J Mol Cell Cardiol, 29, 2187, 10.1006/jmcc.1997.0454

Cao, 2003, Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels, Am J Physiol Heart Circ Physiol, 285, 1032, 10.1152/ajpheart.01004.2002

Pepe, 2004, Cross-talk of opioid peptide receptor and beta-adrenergic receptors signalling in the heart, Cardiovasc Res, 179, 1011

Felten, 1985, Noradrenergic and peptidergic innervation of lymphoid tissue, J Immunol, 135, 755, 10.4049/jimmunol.135.2.755

Abrass, 1985, Characterization of the β-adrenergic receptor of the rat peritoneal macrophages, J Immunol, 138, 1338, 10.4049/jimmunol.135.2.1338

Spengler, 1990, Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumour necrotic factor, J Immunol, 145, 1430, 10.4049/jimmunol.145.5.1430

Sanders, 1985, Role of alpha adrenergic activation in modulating the murine primary antibody response in vitro, J Pharmacol Exp Ther, 232, 395

Fecho, 1993, Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine, Brain Behav Immun, 7, 253, 10.1006/brbi.1993.1026